Navigation Links
Penn researchers find emotional well-being has no influence on cancer survival
Date:10/22/2007

Researchers at the University of Pennsylvania School of Medicine have found that emotional well-being is not an independent factor affecting the prognosis of patients with head and neck cancers. This study appears in the December 1st issue of CANCER.

The belief that a patients psychological state can impact the course and outcome of their cancer is one that has been prominent among patients and medical professionals, alike, says James C. Coyne, PhD, Co-Leader, Cancer Control and Outcomes Program, Abramson Cancer Center; Professor of Psychology in Psychiatry at Penn; and lead author of the study. This belief leads people to seek psychotherapy in the hopes of promoting survival. While there can be lots of emotional and social benefits of psychotherapy, patients should not seek such experiences solely on the expectation that they are extending their lives.

Study participants were enrolled in two Radiation Oncology Group clinical trials and completed a baseline measure of quality of life questionnaire which included an Emotional Well-Being subscale. The outcome measure was overall survival. The study sample included 1,093 patients, and of this group, 646 died during the length of the study. With the coupling of this large sample and the uniformity of treatment and quality of care that is required in a clinical trial, this is one of the methodologically strongest studies in this area to-date.

The researchers found that emotional status was not a predictor of survival among this population. Additionally, no effects were observed when the researchers examined interactions between emotional well-being and study protocol, gender, primary cancer site, or stage of cancer. Therefore, the study reports that this psychologic variable neither affected progression or death directly, nor functioned as a lurking variable.

While this study may not end the debate, it does provide the strongest evidence to-date that psychological factor
'/>"/>

Contact: Kate Olderman Tavella
kate.olderman@uphs.upenn.edu
215-349-8369
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers identify the early makers of Neonatal Sepsis
4. OHSU Researchers Announce New Discovery
5. Researchers Identify Gene Connected To Bipolar Disorder
6. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
7. Researchers trick Alzheimers Enzyme
8. Researchers find new HIV hiding place
9. Gene researchers make Malaria-resistant mosquito
10. New Hair in 15 Days Could Now Be A Possibility Say Researchers
11. Researchers developed world’s smallest toothbrus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...
(Date:12/6/2009)... Joseph W. Belluck of Belluck & Fox, LLP says dangerous substances ... seasons. , ... New York, NY (PRWEB) December 6, ... season, they should be alert to reports of recalls due to ... lawyer., , ,“Close to 230,000 children visit hospital emergency rooms each ...
(Date:12/5/2009)... Type of Blood Cancer Is Most Challenging-- ... oncologists have identified specific genes, dubbed partner genes, that ... of leukemia in infants. By more accurately defining specific ... may benefit from particular treatments. ,, Oncologists also ...
(Date:12/5/2009)... the launch of International Solutions, an innovative new international private medical ... equivalent. In addition to offering customers the flexibility to add or ... budgets, International Solutions enables customers to tailor their benefits to complement ... , ...
(Date:12/4/2009)... LLP employees came together in more than 90 offices nationwide ... the audit, tax and advisory firm,s support for literacy with ... firm,s long history of volunteerism. Instead of holiday parties, our ... holidays for some children," said Tim Flynn, Chairman of KPMG. ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
... Dec. 4, 2007 The High School Musical Rockerz Jammin ... be what kids want most this holiday season, but if ... are used, a season of joy might turn into a ... measuring the loudness of many desired toys, University of California, ...
... In response to the growing body of research ... for Cancer Research (AACR) announces the launch of a ... submissions of papers. This important new journal is the ... from preclinical research to clinical trials. , In the ...
... Our belief in power hierarchies is important in how ... a dissertation by Alexandra Snellman from Uppsala University that ... and ethnic discrimination in various situations. , Discrimination and ... our prejudices but are affected by other factors as ...
... idea that only vertebrates have sophisticated adaptive immune systems ... after being infected by them just once has been ... insects also have a form of immune memory that ... previously encountered. This was just one of the striking ...
... with Millions of Transactions, TAMPA, Fla., ... an,esteemed list of petitioners urging the White ... regulations which prohibit controlled drugs from being,electronically ... e-Prescribing,Controlled Substances Coalition, such regulations are negatively ...
... Make Life Easier for Double Amputee, MEDIA ADVISORY ... Thomas Graham, 24, recent Iraqi War Veteran and,double amputee, ... Baltimore,location, WHAT: The delivery of a special birthday ... of both legs while deployed in Iraq,nothing is deterring ...
Other Medicine News:Health News:Greater parental guidance suggested for noisy toy use 2Health News:AACR introduces Cancer Prevention Research 2Health News:AACR introduces Cancer Prevention Research 3Health News:Ethnic discrimination not only based on prejudice 2Health News:Violent sex acts boost insect's immunity system 2Health News:Violent sex acts boost insect's immunity system 3Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 2Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 3
(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ... biological and chemical threats, announced today that the ... the effectiveness of Valortim® in an inhalation anthrax ... The data are being presented during an ...
(Date:12/4/2009)... 4 Axsun Technologies, Inc., a wholly-owned subsidiary of ... initial development and successful testing of a novel integrated ... this proprietary optical engine design raises the bar on ... for swept source OCT light sources. This approach ...
(Date:12/4/2009)... 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ... that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market its 8mg ramelteon ... by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 1Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 2Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 3Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 4Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 5Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 6Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchjointpain com 51730 1Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchjointpain com 51730 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 1Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 3Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 4
... MKC-1 Akt-mTOR Inhibitor Mechanism, ROCKVILLE, Md., ... ), a clinical-stage pharmaceutical company developing,therapeutics for ... today,announced the presentation of results for its ... carcinoma (RCC) models. The results were,presented at ...
... Significant Efficacy Within One ... Week of Daily ... Nasdaq:,SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today,announced the ... Hyperactivity Disorder (ADHD) experienced significant,improvements in ADHD symptom control within ...
Other Medicine Technology:EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 2EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 3EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 4Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 2Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 3Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 4Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 5Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: